<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0001">
 <label>Table 1</label>
 <caption>
  <p>Sesquiterpene lactones with potential positive effects on MetS, biological effects and mechanisms implicated (structures illustrated in 
   <xref rid="fig0001" ref-type="fig">Figs. 1</xref> and 
   <xref rid="fig0002" ref-type="fig">2</xref>).
  </p>
 </caption>
 <alt-text id="alt0003">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top">No.</th>
    <th valign="top">Compound</th>
    <th valign="top">Class</th>
    <th valign="top">Plant source</th>
    <th valign="top">Biological effects</th>
    <th valign="top">Mechanisms implicated</th>
    <th valign="top">Refs.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top">
     <bold>1</bold>
    </td>
    <td valign="top">Enhydrin</td>
    <td valign="top">Melampolide</td>
    <td valign="top">
     <italic>Smallanthus sonchifolius</italic>
    </td>
    <td valign="top">Hypoglycemic (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">Post-prandial glucose levels (↓) Inhibition of α-glucosidase</td>
    <td valign="top">
     <xref rid="bib0047" ref-type="bibr">Genta et al., 2010</xref>; 
     <xref rid="bib0112" ref-type="bibr">Serra-Barcellona et al., 2017</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>2</bold>
    </td>
    <td valign="top">Polymatin A</td>
    <td valign="top">Melampolide</td>
    <td valign="top">
     <italic>Smallanthus macroscyphus</italic>
    </td>
    <td valign="top">Hypoglycemic (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">Post-prandial glucose levels (↓)</td>
    <td valign="top">
     <xref rid="bib0111" ref-type="bibr">Serra-Barcellona et al., 2014</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>3</bold>
    </td>
    <td valign="top">20-dehydroeucannabinolide</td>
    <td valign="top">Heliangolide</td>
    <td valign="top">
     <italic>Helianthus annuus</italic>
    </td>
    <td valign="top">Antidiabetic (
     <italic>in vivo</italic>) Antioxidant (
     <italic>in vitro</italic>)
    </td>
    <td valign="top">Fasting blood glucose level (↓) DPPH radical and NO scavenging activities</td>
    <td valign="top">
     <xref rid="bib0093" ref-type="bibr">Onoja et al., 2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>4</bold>
    </td>
    <td valign="top">Eremanthin</td>
    <td valign="top">Guaianolide</td>
    <td valign="top">
     <italic>Costus speciosus</italic>
    </td>
    <td valign="top">Hypoglycemic, and hypolipidemic (
     <italic>in vivo</italic>) Antioxidant (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">Blood glucose levels (↓), HbA1c (↓), plasma insulin (↑), tissue glycogen (↑) TC, TG and LDL-C (↓); HDL-C (↑) TBARS levels (↓), GSH (↑), SOD, CAT and GPx (↑) in brain, liver, heart, kidney, and pancreas</td>
    <td valign="top">
     <xref rid="bib0039" ref-type="bibr">Eliza et al., 2009a</xref>, 
     <xref rid="bib0040" ref-type="bibr">2009b</xref>, 
     <xref rid="bib0038" ref-type="bibr">2010</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>5</bold>
    </td>
    <td valign="top">Costunolide</td>
    <td valign="top">Germacrolide</td>
    <td valign="top">
     <italic>Costus speciosus</italic>
    </td>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
   </tr>
   <tr>
    <td valign="top">
     <bold>6</bold>
    </td>
    <td valign="top">Alantolactone</td>
    <td valign="top">Eudesmanolide</td>
    <td valign="top">
     <italic>Inula helenium</italic>
    </td>
    <td valign="top">Antiinflammatory-associated to glucose intolerance and IR (
     <italic>in vitro</italic>) Antiinflamatory- obesity-induced IR (
     <italic>in vitro</italic>) Attenuates lipid accumulation (
     <italic>in vitro</italic>) Antiinflamatory- associated to diabetic nephropathy (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">STAT3 inhibitor. Inhibition of the TLR4 gene expression. Inhibition of TLR4-JNK signaling. IL-6 and MCP-1 (↓). APOC3 expression at both mRNA and protein levels (↓) TNF-α and IL-6 (↓) in diabetic kidney. Serum creatinine and urea nitrogen levels (↓).</td>
    <td valign="top">
     <xref rid="bib0067" ref-type="bibr">Kim et al., 2017a</xref>, 
     <xref rid="bib0068" ref-type="bibr">2017b</xref>; 
     <xref rid="bib0133" ref-type="bibr">Yang et al., 2018</xref>; 
     <xref rid="bib0142" ref-type="bibr">Zhu et al., 2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>7</bold>
    </td>
    <td valign="top">Tirotundin</td>
    <td valign="top">3,10-epoxygermacranolide</td>
    <td valign="top">
     <italic>Tithonia diversifolia</italic>
    </td>
    <td valign="top">Antidiabetic (
     <italic>in vitro</italic>)
    </td>
    <td valign="top">Dual PPARα/γ agonists</td>
    <td valign="top">
     <xref rid="bib0079" ref-type="bibr">Lin, 2012</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>8</bold>
    </td>
    <td valign="top">Tagitinin A</td>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
   </tr>
   <tr>
    <td valign="top">
     <bold>9</bold>
    </td>
    <td valign="top">Tagitinin G</td>
    <td/>
    <td/>
    <td valign="top">Anti-hyperglycemic (
     <italic>in vitro</italic>)
    </td>
    <td valign="top">Glucose uptake in 3T3-L1 adipocytes (↑).</td>
    <td valign="top">
     <xref rid="bib0139" ref-type="bibr">Zhao et al., 2012</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>10</bold>
    </td>
    <td valign="top">Tagitinin I</td>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
   </tr>
   <tr>
    <td valign="top">
     <bold>11</bold>
    </td>
    <td valign="top">1β-hydroxydiversifolin-3-O-methyl ether</td>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
   </tr>
   <tr>
    <td valign="top">
     <bold>12</bold>
    </td>
    <td valign="top">1β-hydroxytirotundin-3-O-methyl ether</td>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
   </tr>
   <tr>
    <td valign="top">
     <bold>13</bold>
    </td>
    <td valign="top">Micheliolide</td>
    <td valign="top">Guaianolide</td>
    <td valign="top">
     <italic>Magnolia compressa</italic>
    </td>
    <td valign="top">Anti-inflammatory- associated to diabetic nephropathy (
     <italic>in vitro</italic>)
     <break/>Anti-hepatic steatosis (
     <italic>in vivo</italic> and 
     <italic>in vitro</italic>)
    </td>
    <td valign="top">Suppressed the glucose-stimulated degradation of IκBα and the subsequent activation of NF-κB in rat glomerular mesangial cells.
     <break/>MCP-1, TGF-β1 and FN (↓)
     <break/>PPAR-γ expression (↑)
     <break/>AMPK/mTOR signaling pathway (↑)
     <break/>NF-кB signaling pathway (↓)
    </td>
    <td valign="top">
     <xref rid="bib0061" ref-type="bibr">Jia et al., 2013</xref>;
     <break/>
     <xref rid="bib0141" ref-type="bibr">Zhong et al., 2018</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>14</bold>
    </td>
    <td valign="top">Byrsonine A</td>
    <td valign="top">Guaianolide dimer</td>
    <td valign="top">
     <italic>Byrsonima crassifolia</italic>
    </td>
    <td valign="top">Hypoglycemic, hypolipidemic and antioxidant (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">Blood glucose levels (↓), serum insulin and pancreatic insulin levels (↑)
     <break/>G6Pase activity (↓) and GK activity (↑)
     <break/>TC, TG, LDL-C and VLDL (↓); HDL-C (↑)
     <break/>TBARS levels (↓), SOD, CAT and GPx (↑) in liver, kidneys, and pancreas
     <break/>TNF-α levels (↓).
    </td>
    <td valign="top">
     <xref rid="bib0051" ref-type="bibr">Gutiérrez and Ramirez, 2016</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>15</bold>
    </td>
    <td valign="top">Byrsonine B</td>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
   </tr>
   <tr>
    <td valign="top">
     <bold>16</bold>
    </td>
    <td valign="top">Lactucain C</td>
    <td valign="top">Guaianolide dimer</td>
    <td valign="top">
     <italic>Lactuca indica</italic>
    </td>
    <td valign="top">Antidiabetic (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">Blood glucose levels (↓)</td>
    <td valign="top">
     <xref rid="bib0058" ref-type="bibr">Hou et al., 2003</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>17</bold>
    </td>
    <td valign="top">8-deoxylactucin</td>
    <td valign="top">Guaianolide</td>
    <td valign="top">
     <italic>Cichorium intybus</italic>
    </td>
    <td valign="top">Anti-inflammatory</td>
    <td valign="top">Inhibition of NF-kB activation.
     <break/>COX-2 inhibition.
    </td>
    <td valign="top">
     <xref rid="bib0020" ref-type="bibr">Cavin et al., 2005</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>18</bold>
    </td>
    <td valign="top">Artemisinin</td>
    <td valign="top">Cadinanolide</td>
    <td valign="top">
     <italic>Artemisia annua</italic>
    </td>
    <td valign="top">Vascular protection (
     <italic>in vivo</italic>)
     <break/>Antidiabetic (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">MCP-1, IFN-γ, IL-6 and TNF-α (↓)
     <break/>Inhibition of atherosclerotic plaque formation
     <break/>Promote the conversion of pancreatic glucagon-producing α cells to insulin-secreting β cells
    </td>
    <td valign="top">
     <xref rid="bib0017" ref-type="bibr">Cao et al., 2020</xref>;
     <break/>
     <xref rid="bib0076" ref-type="bibr">Li et al., 2017</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>19</bold>
    </td>
    <td valign="top">Scoporanolide</td>
    <td valign="top">Guaianolide</td>
    <td valign="top">
     <italic>Artemisia scoparia</italic>
    </td>
    <td valign="top">Antihypertensive (
     <italic>in vivo</italic>)
    </td>
    <td valign="top">Inhibition of plasma ACE activity</td>
    <td valign="top">
     <xref rid="bib0025" ref-type="bibr">Cho et al., 2016</xref>
    </td>
   </tr>
   <tr>
    <td valign="top">
     <bold>20</bold>
    </td>
    <td valign="top">Estafiatin</td>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
    <td valign="top"/>
   </tr>
   <tr>
    <td valign="top">
     <bold>21</bold>
    </td>
    <td valign="top">Cumambrin A</td>
    <td valign="top">Guaianolide</td>
    <td valign="top">
     <italic>Chrysanthemum boreale</italic>
    </td>
    <td valign="top">Antihypertensive (
     <italic>in vivo</italic>)
     <break/>Vasorelaxant (
     <italic>ex vivo</italic>)
    </td>
    <td valign="top">Normalization of blood pressure</td>
    <td valign="top">
     <xref rid="bib0056" ref-type="bibr">Hong et al., 1999</xref>, 
     <xref rid="bib0057" ref-type="bibr">2005</xref>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Reduction (↓); increment (↑); thiobarbituric acid reactive substances (TBARS); reduced glutathione (GSH); superoxide dismutase (SOD); catalase (CAT); glutathione peroxidase (GPx); insulin resistance (IR); Toll-like receptor 4 (TLR4); c-Jun N-terminal kinases (JNK); interleukin 6 (IL-6); monocyte chemoattractant protein 1 (MCP-1); Apolipoprotein C3 (APOC3); AMP-activated protein kinase (AMPK); peroxisome proliferator-activated receptors α and γ (PPARα/γ); nuclear factor kappa B (NF-κB); transforming growth factor beta (TGF-β1); fibronectin (FN); glucose-6-phosphatase (G6Pase); glucokinase (GK); cyclooxygenase 2 (COX-2); interferon-gamma (IFN-γ); tumor necrosis factor α (TNF-α); angiotensin I-converting enzyme (ACE).</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
